BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1482242)

  • 1. [Action of labetalol on norepinephrine myocardial content in left ventricular hypertrophy in hypertensive patients].
    Schwebel C; Fagret D; Tremel F; Siché JP; Boutelant S; de Gaudemaris R; Mallion JM
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1103-6. PubMed ID: 1482242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of norepinephrine content in the myocardium in hypertensive patients with left ventricular hypertrophy].
    Schwebel C; Fagret D; Tremel F; Siché JP; Boutelant S; de Gaudemaris R; Mallion JM
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1099-102. PubMed ID: 1482241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure.
    Kurata C; Wakabayashi Y; Shouda S; Okayama K; Yamamoto T; Ishikawa A; Suzuki K; Ishizuka T; Sakamoto S; Tawarahara K
    J Nucl Med; 1995 Nov; 36(11):2037-43. PubMed ID: 7472594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms.
    Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
    Kuwahara T; Hamada M; Hiwada K
    J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis.
    Fagret D; Wolf JE; Vanzetto G; Borrel E
    J Nucl Med; 1993 Jan; 34(1):57-60. PubMed ID: 8418271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.
    Giordano A; Melina G; Calcagni ML; Schinzari F; Cirillo F; Mettimano M; Cardillo C; Melina D
    Arch Med Res; 2007 Jul; 38(5):512-8. PubMed ID: 17560456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy].
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Sugihara H; Takeda K
    Kaku Igaku; 1995 Oct; 32(10):1107-12. PubMed ID: 8523833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging.
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Ida K; Sugihara H; Takeda K; Nakagawa M
    Eur J Nucl Med; 1996 Jul; 23(7):756-61. PubMed ID: 8662113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
    Dubois EA; Kam KL; Somsen GA; Boer GJ; de Bruin K; Batink HD; Pfaffendorf M; van Royen EA; van Zwieten PA
    Eur J Nucl Med; 1996 Aug; 23(8):901-8. PubMed ID: 8753678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension.
    Sakata K; Yoshida H; Tamekiyo H; Obayashi K; Nawada R; Doi O; Mori N
    Drugs Exp Clin Res; 2003; 29(3):117-23. PubMed ID: 14708457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy.
    Schofer J; Spielmann R; Schuchert A; Weber K; Schlüter M
    J Am Coll Cardiol; 1988 Nov; 12(5):1252-8. PubMed ID: 3170968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.
    Fagret D; Wolf JE; Comet M
    Eur J Nucl Med; 1989; 15(9):624-8. PubMed ID: 2574671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of myocardial sympathetic innervation in response to hypoxia.
    Scherrer-Crosbie M; Mardon K; Cayla J; Syrota A; Merlet P
    J Nucl Med; 1997 Jun; 38(6):954-7. PubMed ID: 9189149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.
    Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M
    Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic imaging with 123I-metaiodobenzylguanidine as a marker of cardiac adrenergic neurotransmission in the rat.
    Gayheart-Walsten P; Snyder D; Mack J; Boland C; Roberts J
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):249-54. PubMed ID: 7475511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympathetic reinnervation following heart transplantation--a double-tracer study with 123I-MIBG and 201Tl].
    Gürtner C; Klepzig H; Lelbach S; Krause BJ; Hartmann A; Maul FD; Kranert WT; Hör G
    Nuklearmedizin; 1994 Jun; 33(3):106-12. PubMed ID: 8090624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Nucl Med; 1999 Jan; 40(1):6-11. PubMed ID: 9935049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart: a marker for myocardial dysfunction?
    Herman LM; Dai S; Hartman NG; McNeill JH
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1162-7. PubMed ID: 7882180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.